Resveratrol protects against isoproterenol induced myocardial infarction in rats through VEGF-B/AMPK/eNOS/NO signalling pathway

References

• Jayalakshmi R, Niranjali Devaraj S. Cardioprotective effect of tincture of Crataegus on isoproterenol-induced myocardial infarction in rats. J Pharm Pharmacol. 2004;56(7):921–926.
   PubMed Web of Science ®Google Scholar
• Hu J, Zhang YX, Wang L, et al. Protective effects of Xinji’erkang on myocardial infarction induced cardiac injury in mice. BMC Complement Altern Med. 2017;17(1):338.
   PubMedGoogle Scholar
• Reddy K, Khaliq A, Henning RJ. Recent advances in the diagnosis and treatment of acute myocardial infarction. World J Cardiol. 2015;7(5):243–276.
   PubMed Web of Science ®Google Scholar
• Bloom S, Cancilla PA. Myocytolysis and mitochondrial calcification in rat myocardium after low doses of isoproterenol. Am J Pathol. 1969;54(3):373–391.
   PubMed Web of Science ®Google Scholar
• Panda S, Kar A, Biswas S. Preventive effect of Agnucastoside C against isoproterenol-induced myocardial injury. Sci Rep. 2017;7(1):16146.
   PubMedGoogle Scholar
• Nwokocha C, Palacios J, Simirgiotis MJ, et al. Aqueous extract from leaf of Artocarpus altilis provides cardio-protection from isoproterenol induced myocardial damage in rats: negative chronotropic and inotropic effects. J Ethnopharmacol. 2017;203:163–170.
   PubMed Web of Science ®Google Scholar
• Pasupathy S, Tavella R, Grover S, et al. Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction reduces myocardial infarct size (the NACIAM trial [N-acetylcysteine in acute myocardial infarction]). Circulation. 2017;136(10):894–903.
   PubMed Web of Science ®Google Scholar
• Zhu H, Gao M, Gao X, et al. Vascular endothelial growth factor-B: impact on physiology and pathology. Cell Adhes Migr. 2018;12(3):215–227.
   PubMed Web of Science ®Google Scholar
• Li J, Xie C, Zhuang J, et al. Resveratrol attenuates inflammation in the rat heart subjected to ischemia-reperfusion: role of the TLR4/NF-κB signaling pathway. Mol Med Rep. 2015;11(2):1120–1126.
   PubMed Web of Science ®Google Scholar
• Cong X, Li Y, Lu N, et al. Resveratrol attenuates the inflammatory reaction induced by ischemia/reperfusion in the rat heart. Mol Med Rep. 2014;9(6):2528–2532.
   PubMed Web of Science ®Google Scholar
• Dong W, Yang R, Yang J, et al. Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway. Int J Clin Exp Pathol. 2015;8(8):8731–8741.
   PubMed Web of Science ®Google Scholar
• Goh SS, Woodman OL, Pepe S, et al. The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms. Antioxid Redox Signal. 2007;9(1):101–113.
   PubMed Web of Science ®Google Scholar
• Wallerath T, Deckert G, Ternes T, et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation. 2002;106(13):1652–1658.
   PubMed Web of Science ®Google Scholar
• Leikert JF, Räthel TR, Wohlfart P, et al. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation. 2002;106(13):1614–1617.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang Y, Zhu M, et al. Resveratrol attenuates myocardial ischemia/reperfusion injury through up-regulation of vascular endothelial growth factor B. Free Radic Biol Med. 2016;101:1–9.
   PubMed Web of Science ®Google Scholar
• Robciuc MR, Kivelä R, Williams IM, et al. VEGFB/VEGFR1-induced expansion of adipose vasculature counteracts obesity and related metabolic complications. Cell Metab. 2016;23(4):712–724.
   PubMed Web of Science ®Google Scholar
• Uğurel SS, Kuşçu N, Özenci ÇÇ, et al. Resveratrol prevented lipopolysaccharide-induced endothelial dysfunction in rat thoracic aorta through increased eNOS expression. Balk Med J. 2016;33(2):138–143.
   PubMed Web of Science ®Google Scholar
• Zhao T, Zhao W, Chen Y, et al. Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart. Int J Cardiol. 2013;167(6):2638–2645.
   PubMed Web of Science ®Google Scholar
• Kivelä R, Bry M, Robciuc MR, et al. VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart. EMBO Mol Med. 2014;6(3):307–321.
   PubMed Web of Science ®Google Scholar
• Huusko J, Lottonen L, Merentie M, et al. AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy. Mol Ther. 2012;20(12):2212–2221.
   PubMed Web of Science ®Google Scholar
• Reihill JA, Ewart MA, Salt IP. The role of AMP-activated protein kinase in the functional effects of vascular endothelial growth factor-A and -B in human aortic endothelial cells. Vasc Cell. 2011;3:9.
   PubMedGoogle Scholar
• Bagul PK, Deepthi N, Sultana R, et al. Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3. J Nutr Biochem. 2015;26(11):1298–1307.
   PubMed Web of Science ®Google Scholar
• Ren J, Yang L, Tian W, et al. Nitric oxide synthase inhibition abolishes exercise-mediated protection against isoproterenol-induced cardiac hypertrophy in female mice. Cardiology. 2015;130(3):175–184.
   PubMed Web of Science ®Google Scholar
• Francois AA, Obasanjo-Blackshire K, Clark JE, et al. Loss of protein kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury. Cardiovasc Res. 2018;114(1):138–157.
   PubMed Web of Science ®Google Scholar
• Yang L, Cai X, Liu J, et al. CpG-ODN attenuates pathological cardiac hypertrophy and heart failure by activation of PI3Kalpha-Akt signaling. PLOS ONE. 2013;8(4):e62373.
   PubMed Web of Science ®Google Scholar
• Pei H, Song X, Peng C, et al. TNF-alpha inhibitor protects against myocardial ischemia/reperfusion injury via Notch1-mediated suppression of oxidative/nitrative stress. Free Radic Biol Med. 2015;82:114–121.
   PubMed Web of Science ®Google Scholar
• Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2005;15(4):316–328.
   PubMed Web of Science ®Google Scholar
• Yang Y, Duan W, Lin Y, et al. SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radic Biol Med. 2013;65:667–679.
   PubMed Web of Science ®Google Scholar
• Devaux Y, Vausort M, Azuaje F, et al. Low levels of vascular endothelial growth factor B predict left ventricular remodeling after acute myocardial infarction. J Card Fail. 2012;18(4):330–337.
   PubMed Web of Science ®Google Scholar
• Kivelä R, Bry M, Robciuc MR, et al. VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart. EMBO Mol Med. 2014;6(3):307–321.
   PubMed Web of Science ®Google Scholar
• Hollenberg NK. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Curr Hypertens Rep. 2003;5(4):287–288.
   PubMedGoogle Scholar
• Taguchi K, Hida M, Matsumoto T, et al. Resveratrol ameliorates clonidine-induced endothelium-dependent relaxation involving Akt and endothelial nitric oxide synthase regulation in Type 2 diabetic mice. Biol Pharm Bull. 2015;38(12):1864–1872.
   PubMed Web of Science ®Google Scholar